The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review
Authors:
- 28 March 2025
- journal article
- review article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- p. 1-18
Abstract
Baicalein from Scutellaria baicalensis influences miRNA expression in various cancers, affecting key signaling pathways (PI3K/AKT, Wnt/β-catenin, mTOR) and processes like tumor growth, apoptosis, and metastasis. miRNAs, as small non-coding RNAs, play crucial roles in the cancer pathogenesis-associated gene regulations. This study is aimed at systematically reviewing the effects of baicalein on miRNA expression in various cancers. A comprehensive systematic review was conducted following PRISMA guidelines to investigate the impact of baicalein on miRNA expression in cancer. Databases including PubMed, Scopus, and Web of Science were systematically searched using key search terms. Inclusion criteria encompassed studies reporting changes in miRNA expression following baicalein treatment in cancer cell lines and animal models. Data extraction and risk of bias assessment based on SYRCLE’s risk of bias tool were performed to ensure methodological rigor and reliability of the findings. Fifteen studies meeting the inclusion criteria were included in the systematic review. Baicalein impacts miRNA expression in cancers like hepatocellular carcinoma, breast, cervical, ovarian, and gastric cancers, suggesting its potential as a multi-cancer therapeutic. Baicalein regulates tumor-related genes (HDAC10, MDM2, Bcl-2/Bax, and Cyclin E1) and signaling molecules (AKT, FOXO3α), affecting cell viability, apoptosis, and cell cycle, indicating targeted therapeutic potential. In vitro and in vivo studies show baicalein inhibits tumor growth, enhances apoptosis, and regulates cell proliferation, supporting its anticancer effects. Baicalein exhibits potential in modulating miRNA expression in cancer, offering avenues for therapeutic intervention. However, methodological rigor in future studies is essential to enhance the reliability and validity of findings. Comprehensive understanding of baicalein’s effects on miRNA expression holds promise for developing novel cancer treatment strategies.Keywords
This publication has 101 references indexed in Scilit:
- Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2013
- Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 ClustersMolecular Cancer Therapeutics, 2012
- Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancerOncogene, 2011
- The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative EffectsPLOS ONE, 2011
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Nob1 binds the single-stranded cleavage site D at the 3′-end of 18S rRNA with its PIN domainProceedings of the National Academy of Sciences, 2009
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 DegradationMolecular Cell, 2008
- Rap1b is required for normal platelet function and hemostasis in miceJournal of Clinical Investigation, 2005
- Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling PathwayMolecular and Cellular Biology, 2002
- Cloning, expression and genetic mapping of the mouse SH3 domain protein, SH3D2BMammalian Genome, 1998